- Home
- OCC vs LSTA Comparison
OCC vs LSTA Comparison
Compare OCC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- LSTA
- Stock Information
- Founded
- OCC 1983
- LSTA 1980
- Country
- OCC United States
- LSTA United States
- Employees
- OCC N/A
- LSTA N/A
- Industry
- OCC Telecommunications Equipment
- LSTA Misc Health and Biotechnology Services
- Sector
- OCC Industrials
- LSTA Health Care
- Exchange
- OCC Nasdaq
- LSTA Nasdaq
- Market Cap
- OCC 23.4M
- LSTA 20.0M
- IPO Year
- OCC 1996
- LSTA N/A
- Fundamental
- Price
- OCC $3.00
- LSTA $2.10
- Analyst Decision
- OCC
- LSTA Strong Buy
- Analyst Count
- OCC 0
- LSTA 1
- Target Price
- OCC N/A
- LSTA $15.00
- AVG Volume (30 Days)
- OCC 11.4K
- LSTA 10.1K
- Earning Date
- OCC 06-09-2025
- LSTA 05-08-2025
- Dividend Yield
- OCC N/A
- LSTA N/A
- EPS Growth
- OCC N/A
- LSTA N/A
- EPS
- OCC N/A
- LSTA N/A
- Revenue
- OCC $67,561,951.00
- LSTA $1,000,000.00
- Revenue This Year
- OCC N/A
- LSTA N/A
- Revenue Next Year
- OCC N/A
- LSTA N/A
- P/E Ratio
- OCC N/A
- LSTA N/A
- Revenue Growth
- OCC N/A
- LSTA N/A
- 52 Week Low
- OCC $2.02
- LSTA $1.87
- 52 Week High
- OCC $7.00
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- OCC 48.32
- LSTA 39.57
- Support Level
- OCC $3.06
- LSTA $2.30
- Resistance Level
- OCC $3.28
- LSTA $2.46
- Average True Range (ATR)
- OCC 0.19
- LSTA 0.16
- MACD
- OCC 0.05
- LSTA -0.02
- Stochastic Oscillator
- OCC 45.16
- LSTA 6.25
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.